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Abstract
Background: Type II secretion systems (T2SS) and the evolutionarily related type IV pili (T4P) are important virulence
determinants in many Gram-negative bacterial pathogens. However, the roles of T2SS and T4P in the virulence of
extraintestinal pathogenic Escherichia coli have not been determined.
Methodology/Principal Findings: To investigate the functions of putative T2SS and T4P gene clusters present in the model
uropathogenic E. coli (UPEC) strains UTI89 and CFT073, we deleted the secretin gene present in each cluster. The secretin
forms a channel in the outer membrane that is essential for the function of T2S and T4P systems. We compared the secretin
deletion mutants with their wild type counterparts using tissue culture assays and the CBA/J mouse model of ascending
urinary tract infection. No deficiencies were observed with any of the mutants in adherence, invasion or replication in
human bladder or kidney cell lines, but UTI89 DhofQ and UTI89 DgspD exhibited approximately 2-fold defects in fluxing out
of bladder epithelial cells. In the mouse infection model, each of the knockout mutants was able to establish successful
infections in the bladder and kidneys by day one post-infection. However, UTI89 DhofQ and a CFT073 DhofQ DyheF double
mutant both exhibited defects in colonizing the kidneys by day seven post-infection.
Conclusions/Significance: Based on our results, we propose that the putative T4P and T2S systems are virulence
determinants of UPEC important for persistence in the urinary tract, particularly in renal tissues.
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Introduction
Escherichia coli are a diverse group of Gram-negative bacteria
that can be divided into three major subgroups: commensals in the
intestinal tract of warm-blooded mammals, agents of intestinal
infections such as hemmorhagic colitis and hemolytic-uremic
syndrome, and extra-intestinal pathogenic E. coli (ExPEC) [1].
ExPEC are causative agents of a range of diseases, including
urinary tract infections (UTIs), nosocomial pneumonia, neonatal
meningitis, and neonatal sepsis. UTIs comprise a range of
disorders, including cystitis (infection of the bladder) and
pyelonephritis (infection of the kidney), which are defined by the
presence of microorganisms in the otherwise sterile urinary tract.
UTIs are one of the most common bacterial infections, with an
estimated 33% of women in the United States suffering from a
UTI requiring antimicrobial therapy by the age of 24 and 40–50%
of women experiencing a UTI at least once during their lifetime
[2,3]. Even though UTIs are associated with minimal morbidity,
the annual financial costs associated with their incidence are
estimated at a staggering 2 billion dollars for the US alone [2,3].
There are many known microbial causative agents of UTIs,
including Candida albicans, Pseudomonas aeruginosa, Staphylococcus
saprophyticus, and E. coli. Of these, uropathogenic E. coli (UPEC)
are of special interest because they cause approximately 40% of
hospital and 80% of community acquired UTIs [4]. The success of
UPEC as pathogens can be attributed to their panoply of virulence
factors. These include a variety of toxins, such as cytotoxic and
necrotizing factor 1 (CNF1), hemolysin (hlyA), and secreted
autotransporter toxin (Sat), and a diverse range of adhesins,
including type 1 and P pili. CNF1 is a dermonecrotic toxin that
increases the invasiveness of UPEC by activating Rho GTPases [5]
and also modulates the function(s) of polymorpho-nuclear
leukocytes (PMNs) [6]. HlyA targets erythrocytes and leukocytes
to bring about cell lysis [1], but exactly how it aids UPEC
virulence is unknown [6]. Sat is a cytolytic vacuolating toxin that
has been shown to damage the glomerular membrane and
proximal tubule cells in the kidney, and to create lesions in
intestinal and renal epithelial cell tight junctions [7,8]. The
adhesins present at the tips of type 1 and P pili, FimH and PapG,
respectively, aid UPEC in adhering to the bladder and kidney
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invasin, causing reorganization of the actin cytoskeleton and
localized alterations in the host cell membrane [11]. Thus, a
variety of structurally and functionally different virulence factors
work to aid the pathogenesis of UPEC in the host urinary tract.
Until recently, UPEC were considered to be predominantly
extracellular pathogens of the urinary tract. Even though there
were reports showing UPEC internalization by mouse bladder
superficial epithelial cells, this was considered a result of
phagocytosis by the bladder epithelium [12]. In 1998, it was
shown that UPEC adhere to and invade cells of the bladder
epithelium in a FimH-dependent manner [9]. Once internalized,
the bacteria escape the endosomes by an unknown mechanism
and start replicating in the host cytoplasm to form biofilm-like
structures termed intracellular bacterial communities (IBCs). The
growing IBCs push against the epithelial cell membrane giving it a
pod-like appearance [13]. A recent study found that by 1 h post
infection with 10
7 colony forming units (CFU) of the UPEC strain
UTI89, approximately 50% of the bacteria in the murine bladder
were intracellular, and by 6 h post infection 20 to 210 IBCs per
bladder were detected [14]. In response to replicating bacterial
loads, epithelial cells exfoliate and are purged by urine flow as part
of an innate immune response. PMNs are also recruited to sites of
UPEC infection. Intracellular niches are considered to provide the
UPEC a safe haven away from the host’s immune defenses. UPEC
escape the exfoliating cells by fluxing out and invading the
underlying layers of cells [9,15].
Type II secretion systems (T2SS) are involved in the secretion of
many important effectors in diverse Gram-negative pathogenic
bacteria [16,17]. For example, the secretion of cholera toxin is
mediated by the Eps T2SS in Vibrio cholerae [18] and enterotoxi-
genic E. coli (ETEC) employ a T2SS to secrete heat labile
enterotoxin (LT) [19]. The entire T2SS apparatus, termed the
secreton [20], spans the bacterial envelope. Structurally as well
functionally, the components of the secreton form three subas-
semblies: an outer membrane (OM) channel formed by the
secretin [21], a platform of proteins associated with the
cytoplasmic membrane [22], and a set of proteins that are
proposed to assemble into a pilus-like structure (the pseudopilus) in
the periplasm [23]. The secretin is a member of a family of gated
pores that also includes proteins involved in type IV pilus (T4P)
biogenesis, filamentous phage extrusion, and the type III secretion
system [24]. The pseudopilus is proposed to propel effector
molecules across the OM through the secretin by undergoing
cycles of extension and retraction within the periplasm [23]. The
cytoplasmic membrane platform of proteins is thought to act as an
assembly point for the pseudopilus and to provide energy to drive
the secretion process [22].
The components of the T2SS are similar to the evolutionarily
related T4P system. T4P are adhesive appendages on the bacterial
surface that perform a variety of functions, including twitching
motility, adhesion, biofilm formation, and horizontal genetic
transfer [25,26]. E. coli K12, the common laboratory strain,
possesses gene clusters coding for a T2SS as well as for T4P
biosynthesis. The K12 T2SS and T4P appear to be non-functional
under standard culture conditions, although the T2SS was shown
to mediate the secretion of chitinase in the absence of the nucleoid
structuring protein H-NS [27] and the T2SS secretin gene was
found to be required for surface expression of the DraD invasin
[28]. The putative major pilin of the K12 T4P, PpdD (prepilin
peptidase dependent protein D), could be assembled into pili when
ectopically expressed in Pseudomonas aeruginosa [29] and Klebsiella
oxytoca [30]. In addition, recent studies demonstrated that
enterohemorrhagic E. coli (EHEC) O157:H7 expresses functional
T4P composed of PpdD when grown on minimal casein medium
[31,32]. Both T2SS and T4P have well-studied roles in the
virulence of intestinal pathogenic E. coli. ETEC secretes heat labile
enterotoxin via a T2SS [19] and employs T4P (longus pili) as a
colonization factor [33]. Enteropathogenic E. coli (EPEC) use T4P
(bundle-forming pili) for localized adherence in the intestinal tract
and autoaggregation [34]. In contrast to these established
functions in intestinal pathogenic E. coli, roles for T2SS and T4P
in the virulence of ExPEC have not been established.
In this study, we investigated the roles of the putative T2S and
T4P systems in the pathogenesis of the model UPEC strains
CFT073 and UTI89, isolated from patients suffering from
pyelonephritis and cystitis, respectively [35,36]. We constructed
knockout mutations in OM secretin genes to disable the T2SS and
T4P clusters present in CFT073 and UTI89, and compared the
mutant and wild-type (WT) strains under in vitro and in vivo
conditions. Our findings identify the hofQ secretin as a virulence
factor of UTI89, and hofQ and/or the yheF secretin as virulence
determinants of CFT073. In particular, our results show that these
systems are important for persistent infection of the upper urinary
tract.
Results
T2SS and T4P gene clusters in CFT073 and UTI89
UPEC strain CFT073 is a well characterized strain isolated
from the blood of a woman suffering from pyelonephritis [35],
whereas UTI89 is a UPEC strain isolated from a cystitis patient
[36]. Annotated complete genome sequences for both these model
clinical isolates have been published (CFT073, accession
NC_00431; UTI89, accession NC_007946) [37,38]. The T2SS
and T4P genes present in the UTI89 and CFT073 genomes are
shown schematically in Figure 1. Both UPEC clinical isolates
possess gene clusters homologous to the putative T2SS gene
cluster present in E. coli K12 (K12-T2SS). Both UPEC strains also
possess orthologs of the putative T4P genes present in E. coli K12.
The T2SS and T4P genes common to both UTI89 and CFT073
have very high amino acid homology to the corresponding E. coli
K12 systems (91–99% identity, except for the gspI minor prepilin,
which has 84% identity). In addition to these K12-homologous
genes, UTI89 possesses a second putative T2SS gene cluster that
has 84–97% amino acid homology to a cluster present in ETEC
strain H10407 (ETEC-T2SS). The ETEC-T2SS has relatively low
homology to the K12-T2SS (16–60% amino acid identity). The
ETEC-T2SS cluster is not present in strain CFT073. Nonsense
mutations, insertions, or other disruptions are not present in any of
the T2SS and T4P gene sequences in UTI89 and CFT073,
indicating that these systems are intact and likely to be functional.
To analyze the importance of the putative T2SS and T4P gene
clusters in the pathogenesis of UPEC, we targeted the OM secretin of
each system for deletion mutagenesis using the bacteriophage l Red
recombinase system [39]. The secretin component forms a gated
channel required for export of T2SS effectors or T4P across the OM.
We made single knockout mutations of each of the three secretins
present in UTI89, namely yheF for the K12-T2SS cluster, gspD forthe
ETEC-T2SS cluster, and hofQ for the T4P cluster (Fig. 1). For
CFT073, we constructed single knockout mutations of the yheF and
hofQsecretins, as wellas a doubledeletion strainlacking both secretins
(Fig. 1). Proper construction of the knockout mutations was verified
by PCR (data not shown) using primers specific for the flanking
regions of the targeted genes (Table 1). We also checked each of the
knockout mutants for growth in LB, M63 minimal medium, and in
RPMI supplemented with 10% FBS; growth of each mutant was
similar to the parental WT strain (data not shown).
T2S and T4P Systems in UPEC
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bladder and kidney epithelial cells
The functions of the secretins belonging to the putative T2SS
and T4P gene clusters in UTI89 and CFT073 were first assessed
using a modified gentamicin protection assay [11] (see Methods).
This assay tests the ability of UPEC to adhere to and invade
human urothelial cells, form intracellular replicating foci, and
efflux out of the infected cells. The assay was carried out using the
5637 human bladder and A498 human kidney cell lines. We
observed no defects for the CFT073 or UTI89 secretin knockout
mutants in adhering to or invading the human bladder or kidney
cells compared to the parental WT strains (data not shown). In
addition, no differences were detected in the ability of the
knockout mutants to grow intracellularly in the bladder or kidney
cells, over a period of 48 hours.
Bladder epithelial cells are exfoliated and washed off by urine as
an innate immune response to infection by UPEC [15]. To escape
the exfoliating cells, UPEC efflux out of the infected cells and
spread to other parts of the urinary tract. Interestingly, the UTI89
DhofQ and DgspD strains consistently exhibited approximately 2-
fold reductions (p,0.01) in their ability to efflux out of human
bladder cells as compared to the WT UTI89 strain (Fig. 2). The
UTI89 DyheF mutant also exhibited reduced efflux in some
experiments (Fig. 2), but in experimental replicates, this mutant
was not consistently defective compared to the WT strain. The
efflux defect was specific to the UTI89 cystitis isolate, as none of
the CFT073 secretin knockout mutants exhibited defects in fluxing
out of the bladder cells (data not shown). Furthermore, the efflux
defect occurred only in bladder cells, as each of the UTI89 and
CFT073 secretin knockout mutants fluxed out of kidney cells
similar to the parental WT strains (data not shown). Thus, both
the putative T2S and T4P systems appear to assist the escape of
the UTI89 cystitis isolate, but not the CFT073 pyelonephritis
isolate, from bladder epithelial cells. Attempts to rescue the efflux
defects of the UTI89 mutants by expressing the deleted secretin in
trans from expression plasmids were not successful, and thus we
cannot rule out that the observed defects were caused by
secondary effects of the deletion mutations. However, the
complemented strains exhibited even greater efflux defects
compared to the uncomplemented mutants (data not shown),
suggesting that our inability to complement the deletions may have
been due to constitutive expression of the secretins from an
artificial promoter.
UPEC suppresses the induction of IL-6, a pro-inflammatory
and immunomodulatory cytokine, produced by the urothelium in
response to bacterial LPS and IL-1 [40]. One hypothesis
explaining the mechanism behind the cytokine-suppression is that
UPEC secretes effectors that downregulate host cell NF-kB
signaling to repress transcription of pro-inflammatory and
apoptotic genes [40]. To analyze whether the putative T2SS
and/or T4P gene clusters are involved in the secretion of this
unknown effector, we compared the different UTI89 and CFT073
secretin knockout mutants with their parental WT strains for
ability to suppress IL-6 production in response to LPS by the 5637
Figure 1. Schematic Representation of the T2SS and T4P gene clusters in UTI89 and CFT073. The E. coli K12 and ETEC homologous T2SS
gene clusters are shown in black and red, respectively. T4P genes are shown in blue. For the K12-T2SS, the E. coli K12 gene names are listed above the
arrows and the generic gsp nomenclature is given below. The OM secretin genes are indicated by the hatched arrows. The open arrows are genes
that do not show homology to any of the known T2SS or T4P genes.
doi:10.1371/journal.pone.0004752.g001
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able to suppress IL-6 formation just as well as the WT strains (data
not shown). We also tested whether the UPEC secretins might be
involved in the secretion of a toxic effector molecule. The UTI89
and CFT073 knockout mutants were compared with their
parental WT strains for differences in cytotoxicity toward the
5637 human bladder cell line. None of the mutants exhibited
decreased cytotoxicity, as measured by LDH release during a 3-
hour infection assay (data not shown). In addition, no differences
were detected between WT UTI89 and the secretin knockout
mutants in the amount of LDH released during the efflux assay
carried out as described in Materials and Methods. This indicates
that a defect in secretion of a cytotoxic effector molecule is not
responsible for the decreased efflux of the UTI89 DhofQ and DgspD
strains from bladder epithelial cells.
Roles of the UPEC secretin genes in pathogenesis
To determine the roles of the putative T2SS and T4P gene
clusters in the ability of UPEC to successfully infect the urinary
tract, we tested the UTI89 and CFT073 secretin knockout
mutants using the CBA/J mouse model of ascending UTI [41].
For UTI89, we inoculated 10
7 CFU of the WT strain or one of the
secretin mutants into the bladder by trans-urethral catheterization.
At days 1 and 7 post-infection, animals were sacrificed and CFU/g
of bladder or kidney were determined. All knockout mutants
colonized the bladder and kidneys at levels similar to WT UTI89
on day 1 post-infection (data not shown). All knockout mutants
also colonized the bladder similar to the WT strain on day 7 post-
infection (Fig. 3A). In contrast, the UTI89 DhofQ mutant was
significantly defective in colonizing the kidneys on day 7 post-
infection (p=0.03, Fig. 3B). This defect was specific to the DhofQ
mutant, as the DyheF and DgspD mutants exhibited no significant
defects in kidney colonization (Fig. 4B). Complementation of the
UTI89 DhofQ mutant with plasmid phofQ (expressing WT hofQ)
restored colonization of renal tissue in the CBA/J mouse infection
model to levels similar to the WT strain (Fig 3C). These results
define a specific function for the hofQ secretin, which belongs to the
putative T4P system, in the ability of UTI89 to colonize the
kidney.
We next performed similar experiments with the CFT073
secretin mutants. 10
7 CFU of WT CFT073, the DyheF or DhofQ
single secretin mutant, or the double secretin mutant (DyheF DhofQ)
Table 1. Primers used in this study.
Primer Sequence Size of PCR Product (bp)
WT Knockout
T4P Secretin (hofQ)
Knockout forward TTACTCACTGGAAACCAGTCGTGGCGTGATAAACACCACTAACTCGCGTCGTGTAGGCTGGAGCTGCTTC
Knockout reverse ATGAAGCAATGGATAGCCGCACTACTGTTGATGCTGATACCCGGCGTACACATATGAATATCCTCCTTAGT
Flank forward CATATTGAGTTGTTGAGCTAACTGG 1724 726
Flank reverse GACAATTTTACAGCTGACGCC
RT-PCR forward GATGGTGGATGACGTTCCG 650
RT-PCR reverse AACGTCCGTTGATGCGTCC
Clone forward CAACAAGCTTGTGAGCCGTTTTTCGTTAAGCGTGG (HindIII)
Clone reverse GATAAAGCTTCATCATGGAACGCAGGCAGC (HindIII)
ETEC-T2SS secretin (gspD)
Knockout forward TTAACGCGTTCTCCCGGCATTGAGGAACGCGCGTACTTCCGGCGGTAAGGTGTGTAGGCTGGAGCTGCTT
Knockout reverse GTGTTTTGGCGTGATATGACGTTGTCTATCTGGCGTAAGAAGACAACTGGCATATGAATATCCTCCTTA
Flank forward AGAGAGCGACAACGGATGAACATGG 2343 323
Flank reverse CGCCATTGCGCTAAATCAGC
RT-PCR forward CATACCGTCACGCAAAATGGTC 899
RT-PCR reverse CCAGCAAACACAGTAATGCCCTG
K12-T2SS secretin (yheF)
Knockout forward GGACTCAATAAAATCACCTGCTGCTTGCTGGCAGCACTACTCATGCCTTGTGTGTAGGCTGGAGCTGCTT
Knockout reverse TCACCGTGACGATGGCGCAGGAGCGTGACTGTTGAACGTGTTCTCATCCACATATGAATATCCTCCTTA
Flank forward GAACTTCAGGAATGAATGG 2018 194
Flank reverse TGAATTCTCATAAGAATGCC
RT-PCR forward TGCAGGACACGCTGAGAACG 350
RT-PCR reverse GAACGTTCTCAAGCGGTACG
Clone forward TGCTAAGCTTACAATTCGTCGCAACGGC (HindIII)
Clone reverse AGCGGGATCCTGGCGGGGTACGGTGAGTG (BamHI)
16S rRNA
Forward TGACGGGGGCCCGCACAAGC 222
Reverse CGGCCGGACCGCTGGCAACA
The restriction sites introduced in the cloning primers are indicated in parentheses and their location within the primer sequence is underlined.
doi:10.1371/journal.pone.0004752.t001
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catheterization. As found for UTI89, none of the CFT073 mutants
showed defects in colonizing the bladder or kidneys compared to
WT CFT073 on day 1 post-infection (data not shown). The single
secretin knockout mutants of CFT073 also showed no significant
defects in colonizing the urinary tract on day 7 post-infection
(Fig. 4A and B). However, bacterial titers recovered from kidneys
on day 7 post-infection of mice infected with the CFT073 DyheF
DhofQ double mutant were significantly lower (p=0.013) com-
pared to WT CFT073 (Fig. 4B). In addition, we noted consistently
reduced, though not statistically significant, median bacterial titers
recovered from the bladders of mice infected with the double
knockout strain (Fig. 4A). To confirm the specificity of the kidney
phenotype for the CFT073 DyheF DhofQ double mutant, we
complemented this strain with either yheF or hofQ in trans, using
plasmids pyheF or phofQ, respectively. Complementation with
phofQ significantly restored kidney colonization (Fig. 4C). Com-
plementation with pyheF also increased bacterial colonization in
the kidney, but this did not reach statistical significance (Fig. 4C).
These results demonstrate a specific role for hofQ, belonging to the
putative T4P system, and likely also yheF, belonging to the putative
K12-T2SS in the ability of CFT073 to persist within the urinary
tract, particularly in the kidneys.
Discussion
Many Gram-negative bacterial pathogens use the T2SS and the
evolutionarily related T4P system to secrete and/or assemble
virulence factors. Although functions for these secretion pathways
have been established for intestinal pathogenic E. coli, their roles in
the virulence of ExPEC have not been investigated. In this report,
we begin to address this question by constructing deletion
mutations to disable putative T2SS and T4P gene clusters present
in the genomes of the model UPEC strains UTI89 and CFT073.
Figure 2. Efflux of UTI89 WT and secretin mutant strains from
5637 human bladder epithelial cells. A modified gentamicin
protection assay (see Materials and Methods) was used to calculate
efflux of WT UTI89 or the indicated deletion mutant from monolayers of
5637 human bladder epithelial cells. Cell lines were infected with
bacteria the previous day and incubated overnight in the presence of
gentamicin to kill extracellular bacteria. Cells were then incubated for
6 h in the absence of gentamicin. The efflux index was calculated by
dividing the number of bacteria released into the medium after the 6 h
incubation without gentamicin by the intracellular bacteria present
after the overnight incubation. The efflux index for each strain was
normalized to the WT strain. The UTI89 DgspD and DhofQ mutants
consistently exhibited significantly reduced efflux index values com-
pared to bladder cells infected with WT UTI89. Efflux index values for
the UTI89 DyheF mutant were not always reduced compared to WT.
Each deletion mutant was compared with the WT strain at least 3 times.
Values are shown as a percentage of WT; error bars indicate SD; *,
p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0004752.g002
Figure 3. Mouse infection experiments with UTI89. Eight week-
old, female CBA/J mice were infected by trans-urethral catheterization
with the indicated WT or secretin knockout strains of UTI89. Bladders
and kidneys were harvested on day 7 post-infection, weighed,
homogenized and CFU/g of organ weight determined. The UTI89
DhofQ mutant was consistently defective in colonizing kidneys
(p=0.03) (B), whereas no differences were observed in CFU recovered
from the bladder (A). The kidney colonization defect of UTI89 DhofQ
(p=0.027) was rescued by reintroduction of hofQ in trans (p=0.013) (C).
The bars indicate median CFU values. The limit of detection is indicated
by the dotted line. In panels (A) and (B), the data from two independent
experiments were combined together. Panel (C) shows data from one
experiment. P values were calculated by Mann-Whitney test for non-
parametric data with one-tailed P value.
doi:10.1371/journal.pone.0004752.g003
T2S and T4P Systems in UPEC
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in vitro and in vivo assays. Our results show that putative T4P
and/or T2S systems are important to the pathogenesis of UPEC in
the urinary tract, particularly in the ability to successfully colonize
and persist within the kidneys.
Both the cystitis isolate UTI89 and the pyelonephritis isolate
CFT073 possess putative T2SS and T4P gene clusters sharing very
close homology (generally 91–99% amino acid identity) with genes
present in E. coli K12. In K12 strains, the T2SS does not appear to be
expressed under standard growth conditions, but this system was
shown to be de-repressed in mutants lacking the nucleotide
structuring protein H-NS and to function in the secretion of chitinase
[27]. Similarly, the E. coli K12 T4P genes are transcribed at low levels
and T4P are not detected under standard laboratory conditions [29].
Indeed, we were unable to detect expression of T4P by the UPEC
strains grown under a variety of conditions using whole-bacteria,
negative-stain electron microscopy (R.K. and D.G.T., unpublished
data).We note that a recent study showed that the major pilin subunit
PpdD (HcpA) was assembled into T4P in EHEC when the bacteria
were cultured on minimal casein medium [31]. Furthermore,
expression of the ppdDhofBC (hcpABC) gene cluster from EHEC in
an E. coli K12 strain resulted in surface expression of the PpdD pilin,
suggesting that the T4P assembly machinery in K12 strains is
functional [32]. We were also unable to detect differences in proteins
secreted into culture supernatant fractions between the secretin
knockout mutants and the parental UPEC strains (R.K. and D.G.T.,
unpublished data), and thus could not confirm functionality of the
T2SS gene clusters. However, the yheF (gspD)s e c r e t i nw a sr e c e n t l y
found to be required for surface expression of the DraD invasin in
both uropathogenic and laboratory E. coli strains [28], suggesting that
the T2SS gene cluster is functional. Finally, the virulence defects we
observed for the UTI89 DhofQ and CFT073 DyheF DhofQ mutants
support the idea that the K12-homologous T2SS and T4P gene
clusters are functional and expressed under conditions encountered
within the host.
In addition to the K12-homologous systems, the UTI89 cystitis
isolate contains a second putative T2SS cluster homologous to
genes present in ETEC. In ETEC this T2SS enables the secretion
of heat labile enterotoxin, which is critical for pathogenesis in the
intestinal tract [19]. This raises the possibility that the ETEC-
T2SS might allow secretion of a toxin or other virulence factor by
UTI89. Furthermore, since the ETEC-T2SS is absent from the
genome of the CFT073 pyelonephritis isolate, the ETEC-T2SS
might be specifically associated with the ability of UTI89 to cause
cystitis. To check for a correlation between the cystitic nature of a
UPEC strain and the presence of the ETEC-T2SS, we analyzed a
panel of pathogenic and non-pathogenic E. coli isolates by PCR
using ETEC-T2SS specific primer pairs. Results from this analysis
indicated that the ETEC-T2SS gene cluster is widespread among
E. coli clinical isolates, without any apparent correlation with the
origin of the isolate (R.K. and D.G.T., unpublished data).
Examination of the available genome sequences of E. coli strains
by BLAST analysis also showed the ETEC-T2SS to be prevalent.
Thus, CFT073 appears to be an outlier among E. coli strains in
lacking the ETEC-T2SS.
In the CBA/J mouse model of ascending UTI, we found that
the DhofQ mutant of UTI89 was consistently defective in
colonization of kidneys on day 7 post-infection as compared to
WT UTI89. Complementation of UTI89 DhofQ with plasmid-
borne hofQ restored kidney colonization, confirming that the defect
of the knockout mutant was specifically due to loss of the hofQ
secretin. Similar in vivo defects were not observed for the UTI89
DyheF or DgspD mutants. If hofQ is indeed involved the expression
of T4P, these observations reveal a specific role for T4P in the
Figure 4. Mouse infection experiments with CFT073. Eight week-
old, female CBA/J mice were infected by trans-urethral catheterization
with the indicated WT or secretin knockout strains of CFT073. Bladders
and kidneys were harvested on day 7 post-infection, weighed,
homogenized and CFU/g of organ weight determined. The CFT073
DyheF DhofQ double mutant was significantly defective in colonizing
the kidneys (p=0.013) (B), while bladder CFU (A) were lowered as
compared to WT, but this difference was not significant. The kidney
colonization defect of the CFT073 DyheF DhofQ double mutant
(p=0.005) was restored to WT-like levels by plasmid-borne hofQ
(p=0.038) (C). Addition of yheF in trans also increased colonization
levels, but this was not statistically significant (p=0.393) (C). The bars
indicate median CFU values. The limit of detection is indicated by the
dotted line. In panels (A) and (B), the data from two independent
experiments were combined together. Panel (C) shows data from one
experiment. P values were calculated by Mann-Whitney test for non-
parametric data with one-tailed P value.
doi:10.1371/journal.pone.0004752.g004
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pyelonephritogenic isolate CFT073, mutants containing single
deletions of DhofQ or DyheF were able to infect and colonize
bladder and kidney tissues similar to the WT strain. However, a
CFT073 double knockout mutant lacking both yheF and hofQ
showed significantly reduced colonization of the kidney on day 7
post-infection. The CFT073 double mutant also exhibited reduced
bacterial titers in the bladder on day 7 post-infection, although this
reduction was not statistically significant. These results suggest that
both the putative T2S and T4P systems contribute to the ability of
CFT073 to persistently colonize the urinary tract. The two
secretins, yheF and hofQ, from CFT073 may perform overlapping
or redundant functions, explaining why a defect was only detected
in the double knockout strain. Complementation of the CFT073
double mutant with hofQ in trans significantly restored kidney
colonization, but the increased colonization upon expression of
yheF in trans did not reach statistical significance. This could
indicate a more important role for hofQ in colonization of the
kidney, in agreement with the UTI89 results. Alternatively, lack of
full complementation by yheF could be attributed to expression of
yheF from an artificial promoter on the plasmid. Further
investigation is required to determine the specific contributions
of hofQ and yheF to the pathogenesis of CFT073.
We did not observe defects for the UTI89 or CFT073 secretin
knockout mutants in adhesion, invasion, or replication in human
urothelial cells. UPEC adhere to bladder and kidney cells with the
help of type 1 and P pili, and in case of the bladder epithelium
their entry into the superficial umbrella cells is mediated by the
type 1 pilus tip adhesin, FimH [11]. Hence it was expected that
none of the UTI89 or CFT073 knockout mutants, generated by
specifically targeting the secretins from the putative T2SS and T4P
gene clusters, would be defective in adhesion or invasion. In
addition, we did not detect changes in cytotoxicity of the UPEC
mutants toward host cells or ability to suppress IL-6 expression by
the bladder epithelial cells. Thus, these functions in UPEC
presumably are not mediated by the putative T2S and T4P
pathways. Using a modified gentamicin protection assay that
mimics several aspects of UPEC pathogenesis, we did observe that
knockout mutants in UTI89 lacking hofQ and gspD were defective
in fluxing out of the bladder epithelial cell line. This efflux defect
could underlie the in vivo defect observed for the UTI89 DhofQ
mutant, but we do no believe this to be the case, as the UTI89
DgspD mutant had no in vivo phenotype despite being equally
defective for efflux in vitro. Furthermore, no efflux defect was
found for any of the CFT073 secretin mutants. Efflux defects for
the UTI89 DhofQ and DgspD mutants were confirmed by
fluorescence microscopy using green fluorescent protein-express-
ing strains, but these experiments indicated a delay in efflux rather
than an absolute defect (R.K. and D.G.T. unpublished results).
This, together with the relatively small (,2-fold) scale of the
defect, could explain the lack of correlation between the cell
culture and in vivo results.
Based on our findings, and assuming that the putative T2SS and
T4P gene clusters function as expected based on their homology to
established systems, we propose that T4P aid in the colonization and
persistence of UPEC in the urinary tract, particularly the upper
urinarytract.Although,flagellahavebeenimplicated intheascentof
UPEC along the ureters [42], the role for other bacterial factors that
might aid in this process is still undefined. In a number of Gram-
negative pathogens, association with the host epithelium followed by
motility and dispersal over the epithelial surface are mediated by
T4P [43]. T4P in UPEC might play a similar role, although
colonization of the urinary tract at early time points post-infection
were similar in both the mutant and WT strains. Alternatively, T4P
may specifically aid in the colonization of kidney tissues by UPEC,
possibly by mediating bacterial-bacterial and bacterial-host interac-
tions and/or the formation of biofilms. Another possibility is that in
the absenceof functionalT4P and/or theT2SS, themutantbacteria
were defective due to the lack of an unknown secreted effector,
leading to clearance of the bacteria by day 7 post-infection. ExPEC
employabroadarrayofvirulencefactors,includingtype1andPpili,
and secreted toxins such as CNF1, hemolysin and Sat. Our results
suggest this impressive list of weaponry may need to be expanded to
include T4P and possibly also the T2SS, opening new avenues to
understanding the molecular mechanisms of E. coli pathogenesis in
the upper urinary tract.
Materials and Methods
Bacterial Strains and Cell Lines
UPEC strain CFT073 was isolated from the blood of a woman
suffering from pyelonephritis [35] and UPEC strain UTI89 was
isolated from a cystitis patient [36]. The bacteria were grown on
LB agar plates or in LB medium. When needed, the medium was
supplemented with appropriate concentrations of antibiotics:
100 mg/ml ampicillin (Amp), 50 mg/ml kanamycin (Kan) and/or
25 mg/ml chloramphenicol (Clm). Human bladder (5637, ATCC
# HTB-9) and human kidney (A498, ATCC # HTB-14) cell lines
were obtained from the ATCC. 5637 cells were maintained in
RPMI medium supplemented with 10% fetal bovine serum (FBS;
Gemini). A498 cells were maintained in modified Eagle’s medium
(MEM) supplemented with 10% FBS, 16 sodium pyruvate and
16 L-glutamine. For growth and during infection assays, the cell
lines were kept at 37uC in the presence of 5% CO2.
Enumeration of Bacteria
Infected cell lines or organs were treated with 0.4 or 0.02%
triton X-100 in sterile PBS, respectively. The cell monolayers were
then kept at 4uC for 10 min to help lift the cells off the plastic,
while the organs were homogenized using Tenbroeck tissue
grinders (Kontes). The suspensions were then vortexed, serially
diluted in sterile LB broth and 100 ml of appropriate dilutions
were spread on LB agar plates. After incubating the plates at 37uC
overnight, single colonies were counted and CFU/ml or CFU/g of
organ weight calculated.
Generation of knockout mutants
The method described by Datsenko and Wanner [39] was used
to generate genomic deletion mutations in the genes coding for
OM secretins, using the knockout primers listed in Table 1. In
addition, primers flanking the target genes were designed (Table 1)
to confirm proper occurrence of each step in the procedure by
PCR. To generate double knockout mutants, one antibiotic
resistance gene (for example, Kan) was first used to replace one of
the target genes by homologous recombination. A different
antibiotic resistance gene (for example, Cml) was then used to
replace the second target gene. The resultant recombinant
bacteria were screened for disruption of the two different target
loci by growing on LB plates supplemented with kanamycin and
chloramphenicol. Finally after introduction of plasmid-borne FLP
recombinase, colonies were screened for loss of resistance to both
antibiotics. Proper occurrence of each step in the procedure by
was verified by PCR.
Generation of Rescue Plasmids
The genes hofQ and yheF were PCR amplified using cloning
primers listed in Table1. The PCR products were gel purified, ligated
into pGEM T-easy vector (Promega) as per the manufacturer’s
T2S and T4P Systems in UPEC
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Colonies containing pGEM-hofQ and pGEM-yheF were purified, the
plasmids isolated and analyzed by DNA sequencing. The EcoRI
digested fragment from pGEM-hofQ and the BamHI, HindIII
digested fragment from pGEM-yheF were then ligated into
pMMB67HE [44] pretreated with the same restriction endonucleases
to obtain plasmids, phofQ and pyheF. The correct orientation of the
hofQ gene in pMMB67HE was confirmed by the DNA sequencing.
These plasmids were then transformed into appropriate deletion
mutant strains for use in the rescue experiments. Analysis of bacteria
recovered from the mouse infection experiments demonstrated that
t h er e s c u ep l a s m i d sw e r es t a b l ym a i n t a i n e di nt h ea b s e n c eo f
antibiotic selection (data not shown).
Mouse Infections
Bacteria were grown statically in 20 ml LB broth at 37uC for
24–48 h. On the day of animal infection, the bacteria were
centrifuged and pellets resuspended in sterile PBS to ,10
9 CFU/
ml. 6–8 week old CBA/J female mice were anesthetized using
isoflurane and 50 ml of the bacterial suspension or sterile PBS (as a
negative control) was delivered to the bladder by transurethral
catheterization using UV sterilized 0.28 mm inner diameter
tubing (Becton Dickinson) mounted on 30K G needle tips.
Dilutions of all inocula were plated on LB agar to determine input
CFU/ml. Five-to-seven mice were infected with each bacterial
strain. On 1 or 7 days post-inoculation, the animals were killed by
CO2 asphyxiation, dissected and organs (bladders and kidneys)
harvested. Bladders and right side kidneys from 5 infected mice
were homogenized in sterile PBS containing 0.02% triton-X 100,
and serial dilutions were plated on LB agar plates. Each mouse
experiment with the UTI89 and CFT073 knockout mutants was
repeated at least once. Comparison of the UTI89 WT, DhofQ, and
DhofQ/phofQ strains was performed once. Comparison of the
CFT073 WT, DyheF DhofQ, DyheF DhofQ/pyheF and DyheF DhofQ/
phofQ strains was performed twice. All animal research protocols
were approved by the Institutional Animal Care and Use
Committee of Stony Brook University.
Cell Culture Infection Assays
5637 human bladder (ATCC # HTB-9) or A498 Human
kidney (ATCC # HTB-14) cell lines were infected with
appropriate bacterial strains in a modified gentamicin protection
assay designed to assess differences between knockout mutants and
their WT counterparts in one or more cardinal steps of UTI,
namely adhesion, invasion, intracellular replication and efflux.
The assay is described in detail in [11]. In short, confluent
monolayers of appropriate cell lines were grown in 24 well tissue
culture plates. Bacteria, grown statically at 37uC for 48 h were
normalized so as to achieve a multiplicity of infection (MOI) of 6–
8. The initial count (IC, equals total input CFUs) of bacteria was
determined. To facilitate bacterial contact with the host cells,
centrifugation (8006g) was carried out for 5 min. After incubation
for 2 h, the cells in one set of wells were washed with PBS
containing 0.9 mM Mg
2+ and 0.49 mM Ca
2+ (Gibco), and
bacterial CFUs enumerated to give the adherent bacteria (AB;
extracellular adherent bacteria plus any intracellular bacteria).
Bacteria in another set of wells were enumerated without the
washing step to give the total bacteria (TB). The percent
adherence frequency was determined as (AB4TB)6100. A third
set of wells was treated with 100 mg/ml gentamicin for 2 h to kill
all extracellular bacteria. These were then washed with PBS
(Ca
2+/Mg
2+) five times, and the intracellular bacteria (IB)
enumerated. The percent invasion frequency was determined as
(IB4IC)6100.
To measure efflux, the infection steps were carried out as
described above except that after the 2 h treatment with 100 mg/
ml gentamicin, the infected monolayers were washed with PBS
(Ca
2+/Mg
2+) once and were incubated in presence of 10 mg/ml
gentamicin overnight. On day 2, the intracellular bacteria in one
set of wells were enumerated after washing off the gentamicin to
give overnight intracellular bacteria (OB). The other two sets of
wells were washed 5 times with PBS (Ca
2+/Mg
2+) and incubated
for 6 h either in presence or absence of gentamicin. In the absence
of gentamicin, the intracellular bacteria form IBCs and start
effluxing out of the infected cells. The total number of bacteria in
each well was enumerated to give effluxed bacteria (EB; effluxed
plus intracellular bacteria). The efflux index was calculated as
(EB4OB)6100.
IL-6 Suppression Assay
IL-6 suppression assays were carried out as described by
Hunstad et al [40]. Briefly, 24 h old static cultures of bacteria
grown at 37uC were used to infect confluent monolayers of 5637
bladder cells grown in 24 well plates. The bacterial suspension
used for infection contained 5 mg/ml of O157 LPS (Sigma).
Bacterial contact with cells was expedited by centrifuging the
plates at 4006g for 3 min and the plates were then incubated at
37uC in presence of 5% CO2 for 12 h. At the end of the
incubation period, the supernatant fractions were collected, spun
at 13,0006g for 5 min to pellet bacteria and cell debris, and stored
at 280uC until IL-6 estimation by using the human IL-6 ELISA
kit (Antigenix America).
Cytotoxicity Assay
To measure cytotoxicity during bacterial efflux, 5637 human
bladder cells were infected with WT or knockout UPEC strains for
an efflux assay as described above. Upon removal of gentamicin
on the second day of the infection, the supernatant fractions were
collected at 2, 4 and 6 h time points. These fractions were tested
for the presence of lactate dehydrogenase (LDH) using the Cytotox
96 non-radioactive cytotoxicity assay (Promega). To test for instant
cytotoxicity, LDH release was determined after infecting 5637 cells
for 3 h with WT or knockout UPEC strains at an MOI of 5 or 10.
The percent cytotoxicity was calculated as per manufacturer’s
instructions.
Analysis of the T2SS and T4P gene clusters
Percent identities of protein sequences encoded by different
T2SS and T4P genes were assessed using the ClustalW alignment
tool from the Macvector 9.0.1. software program. Values are
reported as percent of entire protein sequence.
Statistical Analysis
The CFU/g of organ weight results from the mouse infection
experiments were compared using the Mann-Whitney test for non-
parametric data with one-tailed P value. The cell culture assay
indices (efflux, adhesion, and invasion) were compared using
Dunnett’s multiple comparisons test. P values ,0.05 were
considered significant.
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